OLBA HEALTHCARE HOLDINGS, Inc. (JP:2689)
:2689
Top Page
OLBA HEALTHCARE HOLDINGS, Inc.
(2689)
Select Model
Select Model
Rating:64Neutral
Price Target:
¥2,240.00
▲(9.54% Upside)
Action:DowngradedDate:03/24/26
The score is driven primarily by solid overall financial stability and growth (moderate leverage, strong recent revenue momentum) tempered by weak and inconsistent cash-flow conversion and thin, pressured margins. Valuation is a meaningful positive (low P/E and solid dividend yield), while technicals are mildly negative in the near term but not strongly bearish overall.
Positive Factors
Revenue Momentum
Sustained top-line acceleration in 2025 indicates strengthening demand and commercial execution. Durable revenue momentum supports scale benefits, helps absorb fixed costs, and provides a base for reinvestment or margin recovery over the next 2–6 months.
Negative Factors
Thin Margins
Structurally thin margins leave limited buffer against cost inflation, supplier pricing pressure, or competitive pricing. Low profitability constrains capacity to self-fund growth or absorb shocks, raising sensitivity to volume swings and operational disruption.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Momentum
Sustained top-line acceleration in 2025 indicates strengthening demand and commercial execution. Durable revenue momentum supports scale benefits, helps absorb fixed costs, and provides a base for reinvestment or margin recovery over the next 2–6 months.
Read all positive factors
OLBA HEALTHCARE HOLDINGS, Inc. (2689) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥12.74B
Dividend Yield3.9%
Average Volume (3M)2.71K
Price to Earnings (P/E)10.7
Beta (1Y)0.32
Revenue Growth3.64%
EPS Growth-4.70%
CountryJP
Employees1,354
SectorHealthcare
Sector Strength45
IndustryMedical - Distribution
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,250,000
10 Day Avg. Volume2,760
30 Day Avg. Volume2,706
Financial Highlights & Ratios
PEG Ratio-2.04
Price to Book (P/B)0.97
Price to Sales (P/S)0.10
P/FCF Ratio65.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model
Company Description
OLBA HEALTHCARE HOLDINGS, Inc. provides various solutions to medical institutions, universities, corporate research institutes, individuals, and long-term care facilities in Japan. The company's medical equipment business engages in the wholesale ...
OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview
Summary
Income Statement
67
Positive
Balance Sheet
74
Positive
Cash Flow
45
Neutral
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 122.70B | 118.56B | 110.47B | 107.96B | 112.98B |
| Gross Profit | 13.91B | 13.60B | 12.95B | 12.50B | 11.60B |
| EBITDA | 2.59B | 2.83B | 2.68B | 2.56B | 1.94B |
| Net Income | 1.43B | 1.50B | 1.41B | 1.54B | 989.37M |
Balance Sheet | |||||
| Total Assets | 45.87B | 43.24B | 40.88B | 39.97B | 36.56B |
| Cash, Cash Equivalents and Short-Term Investments | 3.47B | 2.73B | 2.40B | 3.19B | 2.16B |
| Total Debt | 2.95B | 1.63B | 1.92B | 1.28B | 1.96B |
| Total Liabilities | 33.62B | 31.86B | 30.55B | 30.88B | 28.43B |
| Stockholders Equity | 12.26B | 11.37B | 10.33B | 9.09B | 8.13B |
Cash Flow | |||||
| Free Cash Flow | 181.25M | 1.61B | -910.52M | 1.97B | 2.49B |
| Operating Cash Flow | 1.63B | 2.08B | -659.52M | 2.42B | 3.13B |
| Investing Cash Flow | -1.64B | -673.03M | -306.25M | -211.81M | -630.38M |
| Financing Cash Flow | 686.95M | -1.09B | 175.94M | -1.17B | -2.26B |
OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis
Negative
2045.00
Price Trends
2122.30
Negative
2077.31
Positive
2057.38
Positive
Market Momentum
-3.75
Positive
39.08
Neutral
36.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Negative. The current price of 2045 is below the 20-day moving average (MA) of 2133.75, below the 50-day MA of 2122.30, and below the 200-day MA of 2057.38, indicating a neutral trend. The MACD of -3.75 indicates Positive momentum. The RSI at 39.08 is Neutral, neither overbought nor oversold. The STOCH value of 36.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2689.
OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥40.76B | 11.61 | ― | 2.63% | 0.30% | -31.28% | |
70 Outperform | ¥9.51B | 14.83 | ― | 1.87% | 2.65% | 8.83% | |
64 Neutral | ¥12.74B | 10.68 | ― | 3.90% | 3.64% | -4.70% | |
62 Neutral | ¥41.00B | 10.69 | ― | 0.91% | 15.77% | -50.57% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | ¥18.48B | 14.56 | ― | 1.83% | 4.30% | 52.38% |
* Healthcare Sector Average
JP:2689
OLBA HEALTHCARE HOLDINGS, Inc.
2,093.00
33.45
1.62%
JP:3417
Ohki Health Care Holdings, Inc.
1,340.00
514.53
62.33%
JP:6062
Charm Care Corporation
1,250.00
-48.03
-3.70%
JP:7071
Amvis Holdings.Inc.
417.00
-37.99
-8.35%
JP:9265
YAMASHITA HEALTH CARE HOLDINGS, INC.
3,725.00
838.47
29.05%
OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events
OLBA Healthcare Posts Higher Sales but Profit Decline in First Half, Keeps Full-Year Outlook and Dividend
Jan 30, 2026
OLBA HEALTHCARE HOLDINGS reported modest growth in consolidated net sales for the six months ended December 31, 2025, with revenue up 3.0% year on year to ¥62.4 billion, but profitability weakened as operating profit fell 16.6% to ¥673 m...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.